STXS - Stereotaxis, Inc.

QQQ $ 632.53 $ 0.00 (0 %)

DIA $ 476.21 $ 0.00 (0 %)

SPY $ 684.34 $ 0.00 (0 %)

TLT $ 90.06 $ 0.00 (0 %)

GLD $ 367.51 $ 0.00 (0 %)

Previous Close

$ 2.91

Open

$ 2.92

Bid

$ 2.98 x 60

Ask

$ 3.23 x 1,026

Day's Range

-- - --

52 Week Range

$ 1.54 - $ 3.59

Volume

287,739

Average Volume

Market Cap

263.8M

Beta (5Y Monthly)

$ 1.19

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-13-2025	06-30-2025	10-Q
2	05-13-2025	03-31-2025	10-Q
3	03-14-2025	12-31-2024	10-K
4	11-14-2024	09-30-2024	10-Q
5	08-14-2024	06-30-2024	10-Q
6	05-15-2024	03-31-2024	10-Q
7	03-08-2024	12-31-2023	10-K
8	11-13-2023	09-30-2023	10-Q
9	08-11-2023	06-30-2023	10-Q
10	05-12-2023	03-31-2023	10-Q
11	03-09-2023	12-31-2022	10-K
12	11-14-2022	09-30-2022	10-Q
13	08-11-2022	06-30-2022	10-Q
14	05-11-2022	03-31-2022	10-Q
15	03-10-2022	12-31-2021	10-K
16	11-12-2021	09-30-2021	10-Q
17	08-12-2021	06-30-2021	10-Q
18	05-13-2021	03-31-2021	10-Q
19	03-12-2021	12-31-2020	10-K
20	11-09-2020	09-30-2020	10-Q
21	08-06-2020	06-30-2020	10-Q
22	05-11-2020	03-31-2020	10-Q
23	03-16-2020	12-31-2019	10-K
24	11-14-2019	09-30-2019	10-Q
25	08-09-2019	06-30-2019	10-Q
26	05-09-2019	03-31-2019	10-Q
27	03-15-2019	12-31-2018	10-K
28	11-13-2018	09-30-2018	10-Q
29	08-08-2018	06-30-2018	10-Q
30	05-14-2018	03-31-2018	10-Q
31	03-20-2018	12-31-2017	10-K
32	11-09-2017	09-30-2017	10-Q
33	08-10-2017	06-30-2017	10-Q
34	05-10-2017	03-31-2017	10-Q
35	03-16-2017	12-31-2016	10-K
36	11-10-2016	09-30-2016	10-Q
37	08-10-2016	06-30-2016	10-Q
38	05-11-2016	03-31-2016	10-Q
39	03-11-2016	12-31-2015	10-K
40	11-05-2015	09-30-2015	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Stereotaxis Receives CE Mark, Seeks FDA Ap...
10/15/2025 11:35:59

Stereotaxis (NYSE:STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, tod...

Stereotaxis Enters Collaboration Agreement...
10/13/2025 11:38:53

new-robotic-system-promises-faster-safer-care-for-arrhythmia-patients

New Robotic System Promises Faster, Safer ...
09/22/2025 14:05:15

Stereotaxis (AMEX: STXS) announces first procedures with Genesis Robotic Magnetic Navigation System for minimally invasive endo...

Stereotaxis' Genesis Robotic Magnetic Navi...
09/22/2025 11:59:51

Stereotaxis (NYSE:STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, tod...

Stereotaxis Q2 EPS $(0.05) Beats $(0.07) E...
08/07/2025 20:03:17

Stereotaxis (AMEX:STXS) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(0.07) by ...

Earnings Scheduled For August 7, 2025
08/07/2025 08:33:15

Stereotaxis Receives FDA 510(k) Clearance ...
07/28/2025 11:49:22

Stereotaxis (NYSE:STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, tod...

Stereotaxis Announces $12.5M Registered Di...
07/17/2025 12:33:06

Led by Strategic Industry Partner and Select Institutional InvestorsProceeds Strengthen Balance Sheet and Support Commercializa...

Stereotaxis Publishes First Clinical Resul...
07/01/2025 13:03:41

Stereotaxis Q1 EPS $(0.07), Inline, Sales ...
05/12/2025 20:05:32

Stereotaxis (AMEX:STXS) reported quarterly losses of $(0.07) per share which met the analyst consensus estimate. This is a 16.6...

Earnings Scheduled For May 12, 2025
05/12/2025 08:32:31

whats-going-on-with-stereotaxis-shares-wednesday

What's Going On With Stereotaxis Shares We...
03/19/2025 19:06:20

Stereotaxis shares are moving higher on Wednesday after the company announced it was accepted into the NVIDIA Connect program.

Stereotaxis Accepted Into NVIDIA Connect P...
03/19/2025 12:04:27

Stereotaxis Q4 EPS $(0.09) Misses $(0.07) ...
03/03/2025 12:42:02

Stereotaxis (AMEX:STXS) reported quarterly losses of $(0.09) per share which missed the analyst consensus estimate of $(0.07) b...

Stereotaxis Submits First Robotic Catheter...
03/03/2025 12:33:41

Stereotaxis (NYSE:STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, tod...

Earnings Scheduled For March 3, 2025
03/03/2025 08:32:12

Stereotaxis Receives Order For Its Genesis...
01/30/2025 13:13:45

Stereotaxis Receives European CE Mark Appr...
01/27/2025 13:15:18

Stereotaxis (NYSE:STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, tod...

Stereotaxis' Genesis Robotic System Debuts...
01/14/2025 12:25:35

Stereotaxis (NYSE:STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, tod...

Stereotaxis and MicroPort EP Secure NMPA A...
12/09/2024 12:27:12

Stereotaxis (NYSE:STXS) and Shanghai MicroPort EP Medtech Co., Ltd. (688351.SH, "MicroPort EP"), today announced that t...